What Are Peptides? Chemistry, Types and Research Uses Explained
By UK Peptide Lab Research Team•19 September 2026•9 min read
Key Takeaways
- A peptide is a short chain of amino acids joined by peptide (amide) bonds. By convention, chains under about 50 residues are peptides; longer chains that fold into defined structures are proteins.
- The peptide bond forms by condensation between the carboxyl group of one amino acid and the amine group of the next, releasing water. Its partial double-bond character makes it planar and rigid.
- Research peptides span distinct classes: fragment peptides (BPC-157, AOD-9604), carrier complexes (GHK-Cu), synthetic analogues of hormones (CJC-1295, PT-141) and endogenous sequence copies (TB-500, MOTS-C).
- In the UK, research peptides are not Controlled Drugs and may be bought for laboratory use, but none holds a marketing authorisation, so supply for human consumption is unlawful. Purchasers must be 18 or over.
The Short Answer
A peptide is a short chain of amino acids joined together by peptide bonds. Amino acids are the twenty or so small molecules that biology uses as universal building blocks; string a few of them together and you have a peptide, string together fifty or more and let the chain fold into a stable shape and you have a protein. Everything else in this guide is detail on top of that one sentence.
The word itself comes from the Greek peptos, meaning digested, because the first peptides studied were fragments produced by digesting proteins. That origin still describes a large part of the research field: many of the most-studied research peptides are deliberate fragments or analogues of larger parent molecules.
The Chemistry: What a Peptide Bond Actually Is
Every amino acid has an amine group (-NH2) at one end and a carboxyl group (-COOH) at the other. A peptide bond forms when the carboxyl group of one amino acid condenses with the amine group of the next, releasing a molecule of water and leaving a carbon-nitrogen amide linkage. Chemists call it an amide bond; when it joins amino acids specifically, it is a peptide bond, the same linkage under a context-specific name.
The bond has a property that matters for everything downstream: resonance gives the C-N link partial double-bond character, so the six atoms around it sit in a rigid plane and cannot rotate freely. A peptide chain is therefore not a floppy string but a series of rigid plates connected at flexible hinges, and that geometry is what allows longer chains to fold into the defined structures that make proteins work.
Chains carry direction, too: an N-terminus (free amine) at the start and a C-terminus (free carboxyl) at the end. Sequences are always written N to C, which is why a sequence like Thr-Lys-Pro-Arg-Pro-Gly-Pro (Selank) reads left to right the way it does.
Peptide vs Protein: Where the Line Sits
The conventional boundary is about 50 amino acids. Below it, the molecule is a peptide: usually too short to hold a stable three-dimensional fold on its own, and behaving in solution more like a flexible chain than a structured object. Above it, with folding, the molecule is a protein.
The boundary is fuzzy on purpose. Insulin, at 51 residues across two linked chains, is called a protein by most textbooks and a large peptide by plenty of pharmacologists. What matters for research purposes is not the label but the behaviour: short chains are easier to synthesise chemically, cross membranes and degrade differently, and are handled in the laboratory quite differently from folded proteins.
Within the peptide range itself the naming is systematic: dipeptide (2 residues), tripeptide (3), tetrapeptide (4), then oligopeptide up to about 20 and polypeptide beyond. GHK-Cu is a tripeptide, Epithalon a tetrapeptide, BPC-157 a pentadecapeptide (15), TB-500 a 43-residue polypeptide sitting near the protein boundary.
The Classes Researchers Actually Work With
The research catalogue sorts into a few recurring types, and knowing which type a compound belongs to tells you a lot about how its literature reads.
Fragment peptides are pieces of a larger parent molecule chosen because the fragment retains an activity of interest: BPC-157 corresponds to a partial sequence of a gastric protein, and AOD-9604 is the C-terminal 177-191 fragment of human growth hormone.
Endogenous copies are synthetic versions of sequences the body already makes: TB-500 reproduces thymosin beta-4, and MOTS-C copies a peptide encoded in mitochondrial DNA.
Designed analogues start from a natural template and modify it for stability or selectivity: CJC-1295 is a modified GHRH fragment engineered to resist enzymatic cleavage, PT-141 is a cyclised melanocortin analogue, and Semax extends an ACTH fragment with a proline-glycine-proline tail.
Carrier complexes pair a peptide with a metal ion: GHK-Cu is the tripeptide glycyl-histidyl-lysine chelating copper(II), and most of its studied chemistry runs through the copper.
Cosmetic signal peptides such as Matrixyl (palmitoyl pentapeptide-4) belong to a different commercial world, topical skincare formulation, but chemically they are the same object: short amino acid chains built by the same synthesis.
How Research Peptides Are Made
Essentially all catalogue research peptides are produced by solid-phase peptide synthesis (SPPS). Merrifield introduced the method in 1963 with the synthesis of a tetrapeptide (J Am Chem Soc, 1963) and developed it through the decade (Adv Enzymol, 1969); it earned the 1984 Nobel Prize in Chemistry. The idea is to anchor the first amino acid to an insoluble resin bead, then add amino acids one at a time in repeated coupling-deprotection cycles, washing impurities away between steps. Because the growing chain stays attached to the solid support, the process automates well and scales from milligrams to kilograms.
After assembly the peptide is cleaved from the resin, purified, almost universally by reverse-phase HPLC, the same technique used to verify purity on a certificate of analysis, and freeze-dried into the lyophilised powder that arrives in a vial. That is why research peptides ship as dry powder requiring reconstitution rather than as solutions: the dry solid is far more stable than the dissolved chain.
Why Peptides Are Usually Injected in Medicine (and What Is Changing)
Licensed peptide medicines have historically been injectables, and the reason is digestive chemistry: the gut treats a swallowed peptide as food protein and cuts it apart with the same proteases that digest a meal. The stomach and intestinal wall are, from the point of view of a peptide, a shredder.
The interesting recent exception is oral semaglutide, where the tablet co-formulates the peptide with an absorption enhancer called SNAC that locally raises stomach pH and promotes absorption across the gastric lining (Buckley and colleagues, Sci Transl Med, 2018; reviewed in Rev Endocr Metab Disord, 2022). It remains the exception that proves the rule: making it work took a purpose-designed enhancer and still delivers around 1% bioavailability.
None of this is dosing guidance for research compounds; it is context for reading the literature, where route of administration shapes every pharmacokinetic claim you will encounter.
Peptides in UK Law
Research peptides occupy a specific legal position in the UK, and it is worth stating precisely. They are not Controlled Drugs under the Misuse of Drugs Act 1971, so purchase and possession for laboratory research is lawful and requires no licence. None of them holds a marketing authorisation, which means that under the Human Medicines Regulations 2012 they cannot lawfully be sold or supplied for human consumption, and a supplier making therapeutic claims or publishing dosing guidance is breaking the law. That is the entire logic of research-use-only supply: the sale is lawful as laboratory reagent supply, on the confirmation of research use by the buyer, from age 18. The full picture, including what RUO actually means and where the legal lines sit, is in our guide to whether peptides are legal in the UK.
Reading Purity: What a Certificate Tells You
Because SPPS builds chains step by step, every batch contains truncated or modified sequences at some level, and purity is the fraction of the material that is the intended full sequence. Reverse-phase HPLC separates the components and reports the target peptide as a percentage of total peak area; mass spectrometry confirms the identity of the main peak against the calculated molecular weight.
That pair of numbers, HPLC purity and observed mass, is the core of a genuine certificate of analysis, and per-batch certificates from a named laboratory are the practical marker separating serious suppliers from the rest. Every UK Peptide Lab batch page links its certificate, and the quality and testing page sets out how every batch here is verified.
Where to Go Next
If you came here from a search, the compound-specific guides go deeper than this overview: BPC-157, GHK-Cu, the CJC-1295 vs Ipamorelin comparison, and the rest of the blog index. For laboratory practice, the storage guide and reconstitution guide cover handling, and the peptide calculator does the concentration arithmetic. Everything supplied on this site is for in-vitro laboratory research only, and purchasers must be 18 or over.
Related Products
Disclaimer: This article is for research and educational purposes only. All information provided is not intended as medical advice. UK Peptide Lab products are not for human consumption and are sold strictly for laboratory research use only.
Frequently Asked Questions
What is a peptide in simple terms?
A peptide is a short chain of amino acids, the same building blocks that make up proteins, joined end to end by peptide bonds. Two amino acids joined together form a dipeptide, three a tripeptide, and so on. Once a chain grows beyond roughly 50 amino acids and folds into a stable three-dimensional structure, it is conventionally called a protein instead. Insulin, at 51 residues, sits almost exactly on that boundary.
What is the difference between a peptide and a protein?
Length and folding. Peptides are short chains, usually under about 50 amino acids, and most are too short to hold a stable three-dimensional fold on their own. Proteins are longer chains that fold into defined structures, and that folded structure is what gives them enzymatic or structural function. The boundary is a convention rather than a law of chemistry, but it is the working distinction used across biochemistry.
What does a peptide bond look like chemically?
It is an amide linkage: the carboxyl carbon of one amino acid bonds to the amine nitrogen of the next, with loss of a water molecule. The carbon-nitrogen bond has partial double-bond character from resonance, which makes the peptide unit planar and restricts rotation. That rigidity, repeated along the chain, is what makes defined peptide and protein structure possible.
Are peptides legal in the UK?
Research peptides are not Controlled Drugs under the Misuse of Drugs Act 1971, so buying and possessing them for laboratory use is lawful. None of them holds a marketing authorisation, so under the Human Medicines Regulations 2012 they cannot lawfully be sold or supplied for human consumption. Reputable UK suppliers sell strictly on a research-use-only basis to buyers aged 18 or over. Our guide to peptide legality in the UK covers this in full.
How are research peptides made?
Almost all research peptides are made by solid-phase peptide synthesis (SPPS), the method Bruce Merrifield introduced in 1963 and later received the Nobel Prize for. The growing chain is anchored to an insoluble resin and amino acids are coupled one at a time in cycles, which allows automation and high purity. The finished peptide is cleaved from the resin, purified by HPLC, and usually supplied freeze-dried (lyophilised) for stability.
References
- [1] Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. J Am Chem Soc (1963). View →
- [2] Solid-phase peptide synthesis. Adv Enzymol Relat Areas Mol Biol (1969). View →
- [3] Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Sci Transl Med (2018). View →
- [4] A new era for oral peptides: SNAC and the development of oral semaglutide. Rev Endocr Metab Disord (2022). View →